Finance

Lists
Outlook: 47.1% bullish·5.9% bearish
Go to analysis
NEOG:NASDAQ
Neogen Corp
11,85 $
+1,20%
(+0,14) 1D
12,02 $
+1,43% (+0,17)
After hours
Closed: 9 қаз., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NEOG...
Open
11,71 $
High
12,11 $
Low
11,57 $
Mkt. cap
2,59 млрд
Avg. vol.
4,43 млн
Volume
3,65 млн
52-wk high
14,18 $
52-wk low
5,37 $
EPS
-0,25 $
Beta
1,79
Shares outstanding
218,31 млн
No. of employees
3 мың
Open
11,71 $
High
12,11 $
Low
11,57 $
Mkt. cap
2,59 млрд
Avg. vol.
4,43 млн
Volume
3,65 млн
52-wk high
14,18 $
52-wk low
5,37 $
EPS
-0,25 $
Beta
1,79
Shares outstanding
218,31 млн
No. of employees
3 мың
News stories
From web sources and news partners
Profile
Neogen Corporation is an international food safety company that provides test kits and relevant products to detect dangerous substances in food. The company was founded in 1982 and is based in Lansing, Michigan. The company serves a wide range of countries including Canada, United States, the United Kingdom, parts of Europe, Mexico and Brazil, India, and China, among others. The company operates a product line of over 100 drug detection test kits worldwide for the detection of about 300 abused and therapeutic drugs in animal treatment. In 2009, it became a vendor of the Chinese government and has been engaged in researching China-specific food safety and plant health issues. Wikipedia
About Neogen Corp
CEOJohn Adent
Employees2,64 мың
Founded1982
Headquarters-
SectorMedical device
Websiteneogen.com
Analyst ratings
Based on 3 analysts giving stock ratings to NEOG in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for NEOG in the last 3 months.
Highest
Current 11,85 $
14,00 $ (+18,14%)
Average
14,00 $ (+18,14%)
Lowest
14,00 $ (+18,14%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Westenberg
Piper Sandler
Buy
Maintained
14,00 $
+18,1%
10/07/2026
Subbu Nambi
Guggenheim
Buy
Maintained
14,00 $
+18,1%
09/29/2026
Brandon Vazquez
William Blair
Hold
Maintained
-
-
09/28/2026
Last report
2026 ж. 06 қаз.
Fiscal period
Q1 2027
0,08 $ / 0,05 $
+50,01%beat
Revenue / Est. (USD)
222,80 млн / 208,18 млн
+7,03%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қар.
2026 ж. ақп.
2026 ж. мам.
2026 ж. там.
Revenue
224,69 млн
211,20 млн
225,30 млн
222,80 млн
Cost of goods sold
118,01 млн
112,20 млн
117,50 млн
117,30 млн
Cost of revenue
118,01 млн
112,20 млн
117,50 млн
117,30 млн
Research and development expenses
4,56 млн
3,80 млн
4,90 млн
6,50 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
107,50 млн
98,50 млн
99,80 млн
100,80 млн
Operating expense
112,06 млн
102,30 млн
104,70 млн
107,30 млн
Total operating expenses
230,07 млн
214,50 млн
222,20 млн
224,60 млн
Operating income
-5,38 млн
-3,30 млн
3,10 млн
-1,80 млн
Other non operating income
-477,00 м.
-3,10 млн
4,50 млн
1,40 млн
EBT including unusual items
-20,36 млн
-20,30 млн
-12,10 млн
-14,90 млн
EBT excluding unusual items
-20,36 млн
-20,30 млн
-12,10 млн
-14,50 млн
Income tax expense
-4,44 млн
-3,30 млн
-800,00 м.
-3,00 млн
Effective tax rate
21,80%
16,26%
6,61%
20,13%
Other operating expenses
-
-
-
-
Net income
-15,92 млн
-17,00 млн
-11,30 млн
-11,90 млн
Net profit margin
-7,09%
-8,05%
-5,02%
-5,34%
Earnings per share
0,10
0,09
0,09
0,08
Interest and investment income
592,00 м.
-
-
-
Interest expense
-14,85 млн
-13,90 млн
-13,90 млн
-13,80 млн
Net interest expenses
-14,26 млн
-13,90 млн
-13,90 млн
-13,80 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
23,55 млн
25,62 млн
32,50 млн
27,30 млн
Gain or loss from assets sale
267,00 м.
224,00 м.
-
500,00 м.
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google қолданбалары